Coppell Advisory Solutions »

Lexicon Pharmaceuticals shares owned by Coppell Advisory Solutions

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Coppell Advisory Solutions from 13F filings

Historical chart of Coppell Advisory Solutions investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Coppell Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Coppell Advisory Solutions

Quarter filed Position value Share count Share price at filing
2023-12-31 $80 52 1.54
2023-09-30 $215 113 1.91
2023-06-30 $113 52 2.17
2022-12-31 $215 113 1.91

More positions owned by Coppell Advisory Solutions

First Tr Exchange Traded Fd Iv First Tr Enh New Etf FTSM (FTSM)
First Tr Exchange Traded Fd Vi Tcw Opportunis Etf Fixd (FIXD)
Microsoft Corp MSFT (MSFT)
Apple Aapl (AAPL)
Jp Morgan Chase & Co JPM (JPM)
Kingsmen Resources Ord KNG (KNG)
Spdr Series Trust Spdr Bloomberg Etf Bil (BIL)
Broadcom Avgo (AVGO)
Ishares Trust Short Treas Bd Etf SHV (SHV)
First Trust Large Cap Value Al Com Shs Etf Fta (FTA)
Ishares Trust Core S&p500 Etf Ivv (IVV)
First Trust Exchange-traded Fu Cap Strength Etf FTCS (FTCS)
Vaneck Vectors Etf Trust Invt Grade Fltg Etf FLTR (FLTR)
Vanguard S&p 500 Etf Voo (VOO)
First Tst Value Li Shs Etf FVD (FVD)

View all positions for Coppell Advisory Solutions

Top funds holding Lexicon Pharmaceuticals

Artal Group
BVF
Vanguard Group
Jpmorgan Chase & Co
NEA Management Company
Gail Mannix
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
D. E. Shaw & Co
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Jane Street
Virtus ETF Advisers

View all funds holding Lexicon Pharmaceuticals